NASDAQ: GLMD
Galmed Pharmaceuticals Ltd Stock Ownership - Who owns Galmed Pharmaceuticals?

Insider buying vs selling

Have Galmed Pharmaceuticals Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when GLMD insiders and whales buy or sell their stock.

GLMD Shareholders

What type of owners hold Galmed Pharmaceuticals Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Schonfeld Strategic Advisors LLC1.52%25,194$40.31kInstitution
Virtu Financial LLC0.67%11,126$17.80kInstitution
Two Sigma Securities LLC0.67%11,019$17.63kInstitution
Morgan Stanley0.45%7,385$11.82kInstitution
Ubs Group Ag0.07%1,104$1.77kInstitution
Tsfg LLC0.00%17$27.20Institution
Sbi Securities Co Ltd0.00%16$25.60Institution
Federation Des Caisses Desjardins Du Quebec0.00%14$22.40Institution
Wells Fargo Company0.00%9$14.40Institution
Osaic Holdings Inc0.00%5$8.00Institution

1 of 2

GLMD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GLMD3.38%0.00%
SILO5.54%4.53%Net BuyingNet Buying
QLGN0.05%99.95%
ADIL3.02%58.45%
GRI0.18%99.82%

Galmed Pharmaceuticals Stock Ownership FAQ

Who owns Galmed Pharmaceuticals?

Galmed Pharmaceuticals (NASDAQ: GLMD) is owned by 3.38% institutional shareholders, 0.00% Galmed Pharmaceuticals insiders, and 96.62% retail investors. Schonfeld Strategic Advisors LLC is the largest individual Galmed Pharmaceuticals shareholder, owning 25,194.00 shares representing 1.52% of the company. Schonfeld Strategic Advisors LLC's Galmed Pharmaceuticals shares are currently valued at $40.31k.

If you're new to stock investing, here's how to buy Galmed Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.